Anja E. H. Holm CEO

Anja Holm has substantial experience in European regulation of veterinary medicines, including clinical trials, authorization procedures and legislation, and in international negotiations. She worked in the Committee for Veterinary Medicines (CVMP) under the European Medicines Agency for 12 years, including 6 years as Chairperson, with innovative veterinary medicines, gene technology and vaccines. At the Danish Medicines Agency, she was senior scientific officer in veterinary medicine for 18 years and latest held the position as Head of unit for clinical trials.
Early in her career she practiced as a veterinarian for four years and participated in a DNA-vaccine research project at the Danish Virus Institute. Anja holds a degree as Doctor of Veterinary Medicine (DVM) from Copenhagen.

Sofia Josephson CFO

Sofia Josephson has experience in accounting and financial controlling. She currently also works as Controller for VA Automotive, which is a company listed on First North. She has previously worked as accountant at PWC. Sofia Josephson has a Bachelor of Science in Economics from Kristianstad University.

Niels-Erik Manniche Director Regulatory Affair

Niels-Erik Manniche has been a practicing veterinarian but has spent the last 25 years in the animal health pharmaceutical industry, including positions within Regulatory Affairs, Clinical trials, and Pharmacovigilance. He has previously worked for MSD Animal Health, Leo Pharmaceuticals Animal Health, Schering-Plough Animal Health, Intervet Danmark AS, and Pharmacia Denmark Animal Health. Niels-Erik holds a degree as Doctor of Veterinary Medicine (DVM) from Copenhagen.

Carlos N. Velez Director Business Development

Carlos Velez has direct experience in the sourcing, evaluation, and licensing of novel products, including animal health assets. He was previously the Chief Business Officer (CBO) of Lantix Therapeutics UK and has been Director of Business Development at Penwest Pharmaceuticals, where he was responsible for the out-licensing of 505(b)(2) programs as well as the scouting and analysis of neurology in-licensing opportunities. Other previous employers include Forest Labs, Frankel Group (now Huron Consulting) and Genencor International. Carlos holds a B.Sc. in Pharmacy from the Albany College of Pharmacy, a Ph.D. in Pharmacy from the University of North Carolina at Chapel Hill, and an MBA in Finance from the Rochester Institute of Technology.


Press releases and reports via E-mail.